SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 43.31 |
Enterprise Value ($M) | 65.66 |
Book Value ($M) | 3.49 |
Book Value / Share | 0.10 |
Price / Book | 12.40 |
NCAV ($M) | -3.40 |
NCAV / Share | -0.10 |
Price / NCAV | -12.75 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.90 |
Return on Assets (ROA) | -0.56 |
Return on Equity (ROE) | -2.07 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.50 |
Current Ratio | 1.50 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 29.74 |
Assets | 36.63 |
Liabilities | 33.14 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 1.03 |
Operating Income | -49.60 |
Net Income | -30.02 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -35.50 |
Cash from Investing | 19.81 |
Cash from Financing | 13.59 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Armistice Capital, Llc | 8.66 | ||
13D/A | South Lake One, Llc | 28.20 | -31.57 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
27,489 | 182,544 | 15.06 | |
96,067 | 242,185 | 39.67 | |
51,273 | 172,374 | 29.75 | |
53,935 | 217,217 | 24.83 | |
(click for more detail) |
Similar Companies | |
---|---|
OMER – Omeros Corporation | PAHC – Phibro Animal Health Corporation |
PTGX – Protagonist Therapeutics, Inc. | RAPT – RAPT Therapeutics, Inc. |
RCKT – Rocket Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io